Low dose total body irradiation: a potent anti-retroviral agent in vivo

Int J Radiat Oncol Biol Phys. 1989 Jan;16(1):165-70. doi: 10.1016/0360-3016(89)90024-2.

Abstract

Immunosuppression characterizes many human diseases including leukemia and AIDS. Friend virus (FV)-induced murine leukemia is a useful model for studying both malignancy and immunosuppression. In a previous series of experiments, we have demonstrated that untreated FV-infected mice died within 40 days post-infection, whereas infected mice given 150 cGy total body irradiation (TBI) on days 5 and 12 exhibited long-term survival. In this report, we show that no leukemic cells or type C virus particles are found in the spleens of mice treated with TBI. In addition, both NK activity as well as bone marrow cell's proliferative responses to PHA and Con A were fully restored. This treatment produces long term control of FV-induced murine leukemia, and thus might have relevance for the treatment of a number of immunosuppressive diseases including AIDS.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Bone Marrow / immunology
  • Bone Marrow / pathology
  • Female
  • Friend murine leukemia virus
  • Inclusion Bodies, Viral
  • Killer Cells, Natural / immunology
  • Leukemia, Experimental / immunology
  • Leukemia, Experimental / pathology
  • Leukemia, Experimental / radiotherapy*
  • Lymphocyte Activation
  • Mice
  • Mice, Inbred DBA
  • Radiation Dosage
  • Spleen / immunology
  • Spleen / pathology
  • Whole-Body Irradiation*